Role of inositol 1,4,5-trisphosphate receptor in ventral signaling in xenopus embryos

Science

Volumn 278, Issue 5345, 1997, Pages 1940-1943

  Kume, Shoen ^a,b   Muto, Akira ^a   Inoue, Takafumi ^b   Suga, Kei ^b   Okano, Hideyuki ^a,c   Mikoshiba, Katsuhiko ^a,b,d  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR;

ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; ULTRAVIOLET IRRADIATION; XENOPUS;

ACTIVINS; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; BODY PATTERNING; CALCIUM; CALCIUM CHANNELS; CELL DIFFERENTIATION; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; EMBRYONIC INDUCTION; FIBROBLAST GROWTH FACTOR 2; GASTRULA; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INHIBINS; INOSITOL 1,4,5-TRISPHOSPHATE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; XENOPUS;

VERTEBRATA;

EID: 0031439813     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.278.5345.1940     Document Type: Article

References (49)

1. M. J. Berridge, Biochem. J. 220, 345 (1984).
2. C. D. Ferris, R. L. Huganir, S. Supattapone, S. H. Snyder, Nature 342, 87 (1989); N. Maeda, M. Niinobe K. Mikoshiba, EMBO J. 9, 61 (1990).
3. C. D. Ferris, R. L. Huganir, S. Supattapone, S. H. Snyder, Nature 342, 87 (1989); N. Maeda, M. Niinobe K. Mikoshiba, EMBO J. 9, 61 (1990).
4. M. J. Berridge, C. P. Downes, M. R. Hanley, Cell 59, 411 (1989).
5. K. R. Kao, Y. Masui, R. P. Elinson, Nature 322, 371 (1986); J. Cooke and E. J. Smith, Development 102, 85 (1988); K. R. Kao and R. P. Elinson, Dev. Biol. 132, 81 (1989); S. E. Stachel, D. J. Grunwald, P. Z. Myers, Development 117, 1261 (1993).
6. K. R. Kao, Y. Masui, R. P. Elinson, Nature 322, 371 (1986); J. Cooke and E. J. Smith, Development 102, 85 (1988); K. R. Kao and R. P. Elinson, Dev. Biol. 132, 81 (1989); S. E. Stachel, D. J. Grunwald, P. Z. Myers, Development 117, 1261 (1993).
7. K. R. Kao, Y. Masui, R. P. Elinson, Nature 322, 371 (1986); J. Cooke and E. J. Smith, Development 102, 85 (1988); K. R. Kao and R. P. Elinson, Dev. Biol. 132, 81 (1989); S. E. Stachel, D. J. Grunwald, P. Z. Myers, Development 117, 1261 (1993).
8. K. R. Kao, Y. Masui, R. P. Elinson, Nature 322, 371 (1986); J. Cooke and E. J. Smith, Development 102, 85 (1988); K. R. Kao and R. P. Elinson, Dev. Biol. 132, 81 (1989); S. E. Stachel, D. J. Grunwald, P. Z. Myers, Development 117, 1261 (1993).
9. 1c) receptor, blocked dorsal development [K. T. Ault, G. Durmowicz A. Galione, P. L. Harger, W. B. Busa, Development 122, 2033 (1996)].
10. 1c) receptor, blocked dorsal development [K. T. Ault, G. Durmowicz A. Galione, P. L. Harger, W. B. Busa, Development 122, 2033 (1996)].
11. 1c) receptor, blocked dorsal development [K. T. Ault, G. Durmowicz A. Galione, P. L. Harger, W. B. Busa, Development 122, 2033 (1996)].
12. 1c) receptor, blocked dorsal development [K. T. Ault, G. Durmowicz A. Galione, P. L. Harger, W. B. Busa, Development 122, 2033 (1996)].
13. Ventral injection of an antagonist of inositol monuphosphatase, bisphosphonate L-690,330, which is more potent than lithium, failed to induce an ectopic dorsal axis in Xenopus embryos [J. R. Atack, S. M. Cook, A. P. Watt, S. R. Fletcher, C. I. Ragan, J. Neurochem. 60, 652 (1993)].
14. P. S. Klein, D. A. Melton, Proc. Natl. Acad. Sci. U.S.A. 93, 8455 (1996).
15. S. Kume et al., Cell 73, 555 (1993).
16. To prepare an antibody that could block IICR specifically we screened mAbs to the 155 amino acids at the COOH-terminus of the XIP3R protein (8). The mAbs to XIP3R were isolated by fusion of the P3U1 myeloma cell line P3x63AgU1 with spleen cells derived from BALB/c mice immunized with glutathione-S-transferase-XIP3R fusion protein. Initial screenings were done by enzyme-linked immunosorbent assays (ELISA) with TrpE-XIP3R fusion proteins. The serum-free culture supernatant of hybridoma cell lines and commercial mouse IgG used as controls were affinity purified with Ampure IgG purification kits (Amersham), followed by dialysis against injection buffer (88 mM NaCl, 1 mM KCl, 15 mM tris-HCl, pH 7.5). With the assumption that the volume of the 2-cell stage embryo is 1 μl [Y. Chen, L. Huang, M. Solursh, Dev. Biol. 161, 70 (1994)], injection of antibody at 20 ng per embryo into the VMZs of 4-cell stage embryos resulted in the estimated final concentration of mAb of ∼40 μg/ml.
17. S. Kume et al., Dev. Biol. 182, 228 (1997).
18. 2+ release in the presence of control mouse IgG [A. Muto, S. Kume, T. Inoue, H. Okano, K. Mikoshiba, J. Cell Biol. 135, 181 (1996)].
19. K. Fukuda et al., Nature 327, 623 (1987).
20. 2+ indicator dye Fura 2 (Molecular Probe) (20 μM) and m1AChR mRNA (13 ng per embryo) were micro-injected at the 2-cell stage, and then mAb (40 ng per embryo) was injected at the animal poles. Animal pole blastomeres were cut off between the 32-to 128-cell stage. Changes in the fluorescence intensities excited at 340 and 380 nm upon carbachol addition (100 μM) were recorded and analyzed.
21. P. D. Nieuwkoop and J. Faber, The Normal Development Table of Xenopus laevis (North-Holland, Amsterdam, 1967).
22. S. Kume, unpublished observation.
23. To obtain more precise information about the sequence that the inhibitory mAbs recognize, we synthesized a candidate epitope of a 12-residue-long peptide with the sequence GQPAHLNINPQQ (corresponding to residues 2680 to 2691, at the COOH terminal of XIP3R) (8) (Peptide Institute). Both ELISA and protein immunoblot analysis revealed that binding of the mAbs 11B12 and 1G9, but not 7F11, to XIP3R was inhibited in the presence of this peptide (15). Abbreviations for the amino acid residues are as follows: A, Ala; G, Gly; H, His; I, IIe; L, Leu; N, Asn; P, Pro; and Q, Gln.
24. Embryos were injected with 80 ng per embryo of 1G9 or control mouse IgG into the marginal zones of each blastomere at the 2-cell stage. DMZs or VMZs were explanted from stage 10 to 10.5 early gastrula embryos and cultured in 1 x Steinberg's solution.
25. Total RNA was isolated from 10 explants. Reverse transcription was carried out with oligo(dT) primers. The primer pairs we used were described previously (19-23, 25, 26). RT-PCR products were stained with DMA-sensitive dye, SYBR Green I, and analyzed by Fluorolmager (Molecular Dynamics).
26. Y. Sasai, et al., Cell 79, 779 (1994); Y. Sasai, B. Lu, H. Steinbeisser, E. M. De Robertis, Nature 376, 333 (1995).
27. Y. Sasai, et al., Cell 79, 779 (1994); Y. Sasai, B. Lu, H. Steinbeisser, E. M. De Robertis, Nature 376, 333 (1995).
28. A. Hemmati-Brivanlou, O. G. Kelly, D. A. Melton, Cell 77, 283 (1994).
29. W. C. Smith and R. M. Harland, ibid. 70, 829 (1992); W. C. Smith, A. K. Knecht, M. Wu, R. M. Harland, Nature 361, 547 (1993).
30. W. C. Smith and R. M. Harland, ibid. 70, 829 (1992); W. C. Smith, A. K. Knecht, M. Wu, R. M. Harland, Nature 361, 547 (1993).
31. F. Stutz and G. Spohr, J. Mol. Biol. 187, 349 (1986).
32. K. W. Cho, B. Blumberg, H. Steinbeisser, E. M. De Robertis, Cell 67, 1111 (1991).
33. G. Von Dassow, J. E. Schmidt, D. Kimelman, Genes Dev. 7, 355 (1993).
34. V. Gawantka, H. Delius, K. Hirschfeld, C. Blumenstock, C. Niehrs, EMBO J. 14, 6268 (1995).
35. C. R. Kintner and D. A. Melton, Development 99, 311 (1987).
36. C. M. Jones, K. M. Lyons, P. M. Lapan, C. V. E. Wright, B. J. M. Hogan, ibid. 115, 639 (1992); L. Dale, G. Howes, B. M. J. Price, J. C. Smith, ibid., p. 573.
37. C. M. Jones, K. M. Lyons, P. M. Lapan, C. V. E. Wright, B. J. M. Hogan, ibid. 115, 639 (1992); L. Dale, G. Howes, B. M. J. Price, J. C. Smith, ibid., p. 573.
38. S. Nishimatsu, A. Suzuki, A. Shoda, K. Murakami, N. Ueno, Biochem. Biophys. Res. Commun. 186, 1487 (1992).
39. 2+ signaling system, Xwnt-5A is a candidate [D. C. Slusarski, J. Yang-Snyder, W. B. Busa, R. T. Moon, Dev. Biol. 182, 114 (1997)].
40. 2+ signaling system, Xwnt-5A is a candidate [D. C. Slusarski, J. Yang-Snyder, W. B. Busa, R. T. Moon, Dev. Biol. 182, 114 (1997)].
41. G. Thomsen et al., Cell 63, 485 (1990); M. Asashima et al., Roux's Arch. Dev. Biol. 198, 330 (1990); J. M. W. Slack, B. G. Darlington, J. K. Heath, S. F. Godsave, Nature 326, 197 (1987); Y. Eto et al., Biochem. Biophys. Res. Commun. 142, 1095 (1987).
42. G. Thomsen et al., Cell 63, 485 (1990); M. Asashima et al., Roux's Arch. Dev. Biol. 198, 330 (1990); J. M. W. Slack, B. G. Darlington, J. K. Heath, S. F. Godsave, Nature 326, 197 (1987); Y. Eto et al., Biochem. Biophys. Res. Commun. 142, 1095 (1987).
43. G. Thomsen et al., Cell 63, 485 (1990); M. Asashima et al., Roux's Arch. Dev. Biol. 198, 330 (1990); J. M. W. Slack, B. G. Darlington, J. K. Heath, S. F. Godsave, Nature 326, 197 (1987); Y. Eto et al., Biochem. Biophys. Res. Commun. 142, 1095 (1987).
44. G. Thomsen et al., Cell 63, 485 (1990); M. Asashima et al., Roux's Arch. Dev. Biol. 198, 330 (1990); J. M. W. Slack, B. G. Darlington, J. K. Heath, S. F. Godsave, Nature 326, 197 (1987); Y. Eto et al., Biochem. Biophys. Res. Commun. 142, 1095 (1987).
45. J. C. Smith, B. M. Price, J. B. Green, D. Weigel, B. G. Herrmann, Cell 67, 79 (1991).
46. J. C. Smith and J. M. Slack, J. Embryol. Exp. Morphol. 78, 299 (1983); L. A. Lattice, J. M. W. Slack, Development 117, 263 (1993).
47. J. C. Smith and J. M. Slack, J. Embryol. Exp. Morphol. 78, 299 (1983); L. A. Lattice, J. M. W. Slack, Development 117, 263 (1993).
48. P. Krieg, S. Varnum, M. Woormington, D. A. Melton, Dev. Biol. 133, 93 (1989).
49. We thank M. Asashima and M. Yuge for invaluable advice. N. Ueno for the Xenopus BMP4 construct, S. Numa for the m1AchR construct, Y. Nishiuchi for synthesis of peptide, Y. Eto for purified human recombinant activin A. K. Okabe, Y. Takeyama, and H. Manki for technical assistance, T. Natsume for discussions, and N. Ueno, J. Aruga, and M. Ohara for critical comments on the manuscript. Supported by grants from the Ministry of Education, Science, Sports and Culture of Japan (H.O. and K.M.) and grants from research fellowships of the Japan Society for the Promotion of Science for Young Scientists (S.K.).